Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor

Stress Protector During prolonged fasting, the oxidation of fatty acids leads to increased accumulation of d-β-hydroxybutyrate (βOHB) in the bloodstream. Such increased concentrations of βOHB inhibit class I histone deacetylases. Histone acetylation in turn influences transcriptional activity at various genes. Shimazu et al. (p. 211, published online 6 December; see the Perspective by Sassone-Corsi) found that among the genes showing increased transcription in animals treated with high concentrations of βOHB were two genes implicated in cellular responses to oxidative stress. When treated ahead of time with βOHB, mice were protected from the toxic effects of the oxidative stress causing poison paraquat. Ketone bodies, metabolites that accumulate during fasting, change gene expression by inhibiting histone deacetylases. [Also see Perspective by Sassone-Corsi] Concentrations of acetyl–coenzyme A and nicotinamide adenine dinucleotide (NAD+) affect histone acetylation and thereby couple cellular metabolic status and transcriptional regulation. We report that the ketone body d-β-hydroxybutyrate (βOHB) is an endogenous and specific inhibitor of class I histone deacetylases (HDACs). Administration of exogenous βOHB, or fasting or calorie restriction, two conditions associated with increased βOHB abundance, all increased global histone acetylation in mouse tissues. Inhibition of HDAC by βOHB was correlated with global changes in transcription, including that of the genes encoding oxidative stress resistance factors FOXO3A and MT2. Treatment of cells with βOHB increased histone acetylation at the Foxo3a and Mt2 promoters, and both genes were activated by selective depletion of HDAC1 and HDAC2. Consistent with increased FOXO3A and MT2 activity, treatment of mice with βOHB conferred substantial protection against oxidative stress.

[1]  D. Williamson,et al.  Physiological roles of ketone bodies as substrates and signals in mammalian tissues. , 1980, Physiological reviews.

[2]  S. Narumiya,et al.  Prostaglandin D2 Protects Neonatal Mouse Brain from Hypoxic Ischemic Injury , 2007, The Journal of Neuroscience.

[3]  M. Guenther,et al.  Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen* , 2001, The Journal of Biological Chemistry.

[4]  A. Hartman,et al.  Ketone bodies in epilepsy , 2012, Journal of neurochemistry.

[5]  S. Nemoto,et al.  Redox Regulation of Forkhead Proteins Through a p66shc-Dependent Signaling Pathway , 2002, Science.

[6]  B. Schwer,et al.  Preparation of enzymatically active recombinant class III protein deacetylases. , 2005, Methods.

[7]  George F Cahill,et al.  Fuel metabolism in starvation. , 2006, Annual review of nutrition.

[8]  O. Owen,et al.  Rapid intravenous sodium acetoacetate infusion in man. Metabolic and kinetic responses. , 1973, The Journal of clinical investigation.

[9]  Christine L Miller,et al.  The high-affinity niacin receptor HM74A is decreased in the anterior cingulate cortex of individuals with schizophrenia , 2008, Brain Research Bulletin.

[10]  R. Nicoll,et al.  Metabolic Control of Vesicular Glutamate Transport and Release , 2010, Neuron.

[11]  J. Rho,et al.  The ketogenic diet in a pill: Is this possible? , 2008, Epilepsia.

[12]  A. Ladurner,et al.  Rheostat control of gene expression by metabolites. , 2006, Molecular cell.

[13]  B. Pitt,et al.  Antioxidant and antiapoptotic function of metallothioneins in HL-60 cells challenged with copper nitrilotriacetate. , 2000, Chemical research in toxicology.

[14]  S. Masino,et al.  Mechanisms of ketogenic diet action , 2010 .

[15]  C. Hoppel,et al.  Novel isolation procedure for short-, medium-, and long-chain acyl-coenzyme A esters from tissue. , 2008, Analytical biochemistry.

[16]  Thomas Nyström,et al.  Role of oxidative carbonylation in protein quality control and senescence , 2005, The EMBO journal.

[17]  Blanka Rogina,et al.  Longevity Regulation by Drosophila Rpd3 Deacetylase and Caloric Restriction , 2002, Science.

[18]  D. Connolly,et al.  (d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G* , 2005, Journal of Biological Chemistry.

[19]  R. Reeves,et al.  Sodium butyrate inhibits histone deacetylation in cultured cells , 1978, Cell.

[20]  A. Hartman Neuroprotection in metabolism-based therapy , 2012, Epilepsy Research.

[21]  J. Morrow,et al.  Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. , 1989, Prostaglandins.

[22]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[23]  Minoru Yoshida,et al.  Chlamydocin analogs bearing carbonyl group as possible ligand toward zinc atom in histone deacetylases. , 2006, Bioorganic & medicinal chemistry.

[24]  L. Laffel Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes , 1999, Diabetes/metabolism research and reviews.

[25]  D. Kipnis,et al.  Hormone-fuel interrelationships during fasting. , 1966, The Journal of clinical investigation.

[26]  G. Turner The Ecology of Adaptive Radiation , 2001, Heredity.

[27]  M. Mehler,et al.  Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis , 2010, Neurobiology of Disease.

[28]  A. Hartman,et al.  The ketogenic diet: Uses in epilepsy and other neurologic illnesses , 2008, Current treatment options in neurology.

[29]  D. Gilbert,et al.  The Ketogenic Diet: Seizure Control Correlates Better With Serum β-Hydroxybutyrate Than With Urine Ketones , 2000, Journal of child neurology.

[30]  Jong M. Rho,et al.  The Ketogenic Diet as a Treatment Paradigm for Diverse Neurological Disorders , 2012, Front. Pharmacol..

[31]  P. Sharp,et al.  Cre-lox-regulated conditional RNA interference from transgenes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Rafael A Irizarry,et al.  Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription. , 2006, Molecular cell.

[33]  L. Guarente,et al.  Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase , 2000, Nature.

[34]  M. Avoli,et al.  Mechanisms of Ketogenic Diet Action -- Jasper's Basic Mechanisms of the Epilepsies , 2012 .

[35]  Ken Nakamura,et al.  Energy Failure , 2013, Annals of neurology.

[36]  Dimitris Thanos,et al.  Ordered Recruitment of Chromatin Modifying and General Transcription Factors to the IFN-β Promoter , 2000, Cell.

[37]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[38]  Geert J. P. L. Kops,et al.  Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress , 2002, Nature.

[39]  S. Benzer,et al.  Life extension in Drosophila by feeding a drug , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  E. Kossoff,et al.  Ketogenic diets: Evidence for short- and long-term efficacy , 2009, Neurotherapeutics.

[41]  O. Dulac,et al.  Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES) , 2010, Epilepsia.

[42]  T. Noakes,et al.  Post‐exercise ketosis. , 1980, The Journal of physiology.

[43]  J. Rho,et al.  Ketone bodies are protective against oxidative stress in neocortical neurons , 2007, Journal of neurochemistry.

[44]  F J Ayala,et al.  Tempo and mode in evolution. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  L. Thompson,et al.  Therapeutic application of histone deacetylase inhibitors for central nervous system disorders , 2008, Nature Reviews Drug Discovery.

[46]  Justin R. Cross,et al.  ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation , 2009, Science.

[47]  C. Van Lint,et al.  The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. , 1996, Gene expression.

[48]  I. Blümcke,et al.  Deep sequencing reveals increased DNA methylation in chronic rat epilepsy , 2013, Acta Neuropathologica.